Patent details

EP2490731 Title: A SYSTEM INCLUDING AN IMPLANTABLE PUMP FOR AN ENHANCED METHOD OF DELIVERING BEVACIZUMAB (AVASTIN) INTO A BRAIN TUMOR

Basic Information

Publication number:
EP2490731
PCT Application Number:
US2010053127
Type:
European Patent Granted for LU
Legal Status:
Unitary Effect Registered
Application number:
EP108254939
PCT Publication Number:
WO2011049906
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
A SYSTEM INCLUDING AN IMPLANTABLE PUMP FOR AN ENHANCED METHOD OF DELIVERING BEVACIZUMAB (AVASTIN) INTO A BRAIN TUMOR
French Title of Invention:
UN SYSTÈME COMPRENANT UNE POMPE IMPLANTABLE POUR UNE MÉTHODE AMÉLIORÉE D'ADMINISTRATION DE BEVACIZUMAB (AVASTIN) DANS UNE TUMEUR CÉRÉBRALE
German Title of Invention:
EIN SYSTEM MIT EINER IMPLANTIERBAREN PUMPE FÜR EIN VERBESSERTES VERFAHREN ZUR VERABREICHUNG VON BEVACIZUMAB (AVASTIN) IN EINEN HIRNTUMOR
SPC Number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
10/06/2024
Link to UPP Register:
European Patent Register
Unitary Effect Request Withdrawal Date:
Unitary Effect Status:
Unitary Effect Registered
Unitary Effect Acceptance Decision Date:
20/06/2024
Unitary Effect Rejection Decision Date:
Unitary Effect Date:
05/06/2024
Unitary Effect Registration Date:
20/06/2024
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Explanatory Text UE:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC Number:

Dates

Filing date:
19/10/2010
Grant date:
05/06/2024
EP Publication Date:
29/08/2012
PCT Publication Date:
28/04/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/06/2024
EP B1 Publication Date:
05/06/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
19/10/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/05/2024
 
 

Name:
Chen, Thomas
Address:
5155 La Canada Blvd., La Canada, CA 91011, United States (US)

Name:
Farkas, Laszlo
Address:
29 Taormina Lane, Ojai CA 93023, United States (US)

Name:
Farkas, Leslie
Address:
254 N. Arnaz Street, Ojai, CA 93023, United States (US)

Name:
Johnson, David
Address:
8450 Delongpre Ave 5, West Hollywood, California 90069, United States (US)

Name:
Marx, Bruce
Address:
1233 Avila Drive, Ojai, California 93023, United States (US)

Name:
Pharmaco-Kinesis Corporation
Address:
10524 S. La Cienega Blvd., Inglewood, CA 90304, United States (US)

Name:
Shachar, Yehoshua
Address:
2417 22nd Street, Santa Monica, CA 90405, United States (US)

Inventor

1

Name:
SHACHAR, Yehoshua
Address:
United States (US)

2

Name:
FARKAS, Laszlo
Address:
United States (US)

3

Name:
MARX, Bruce
Address:
United States (US)

4

Name:
CHEN, Thomas
Address:
United States (US)

5

Name:
JOHNSON, David
Address:
United States (US)

6

Name:
FARKAS, Leslie
Address:
United States (US)

Priority

Priority Number:
581770
Priority Date:
19/10/2009
Priority Country:
United States (US)

Classification

IPC classification:
A61M 5/142; A61M 5/172; C07K 16/22; A61K 39/00;

Publication

European Patent Bulletin

1

Issue number:
202423
Publication date:
05/06/2024
Description:
Grant (B1)

2

Issue number:
202429
Publication date:
17/07/2024
Description:
Unitary Effect Request Receipt

3

Issue number:
202429
Publication date:
17/07/2024
Description:
Unitary Effect Request Receipt

4

Issue number:
202430
Publication date:
24/07/2024
Description:
Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages